1. Home
  2. MDGL vs EAT Comparison

MDGL vs EAT Comparison

Compare MDGL & EAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • EAT
  • Stock Information
  • Founded
  • MDGL 2011
  • EAT 1975
  • Country
  • MDGL United States
  • EAT United States
  • Employees
  • MDGL N/A
  • EAT N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • EAT Restaurants
  • Sector
  • MDGL Health Care
  • EAT Consumer Discretionary
  • Exchange
  • MDGL Nasdaq
  • EAT Nasdaq
  • Market Cap
  • MDGL 6.1B
  • EAT 7.0B
  • IPO Year
  • MDGL N/A
  • EAT N/A
  • Fundamental
  • Price
  • MDGL $302.17
  • EAT $155.90
  • Analyst Decision
  • MDGL Strong Buy
  • EAT Hold
  • Analyst Count
  • MDGL 9
  • EAT 16
  • Target Price
  • MDGL $420.63
  • EAT $158.71
  • AVG Volume (30 Days)
  • MDGL 371.3K
  • EAT 1.3M
  • Earning Date
  • MDGL 08-05-2025
  • EAT 08-13-2025
  • Dividend Yield
  • MDGL N/A
  • EAT N/A
  • EPS Growth
  • MDGL N/A
  • EAT 113.08
  • EPS
  • MDGL N/A
  • EAT 7.16
  • Revenue
  • MDGL $317,383,000.00
  • EAT $5,130,500,000.00
  • Revenue This Year
  • MDGL $286.67
  • EAT $22.62
  • Revenue Next Year
  • MDGL $67.98
  • EAT $5.15
  • P/E Ratio
  • MDGL N/A
  • EAT $21.76
  • Revenue Growth
  • MDGL N/A
  • EAT 19.80
  • 52 Week Low
  • MDGL $200.63
  • EAT $56.27
  • 52 Week High
  • MDGL $377.46
  • EAT $192.22
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 48.85
  • EAT 40.07
  • Support Level
  • MDGL $286.44
  • EAT $151.35
  • Resistance Level
  • MDGL $312.05
  • EAT $168.87
  • Average True Range (ATR)
  • MDGL 14.84
  • EAT 5.28
  • MACD
  • MDGL -3.14
  • EAT -0.48
  • Stochastic Oscillator
  • MDGL 22.01
  • EAT 25.97

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About EAT Brinker International Inc.

Brinker International Inc operates casual dining restaurants under the brand's Chili Grill and Bar (Chili's) and Maggiano's Little Italy (Maggiano's). Chili's falls in the Bar and Grill category of casual dining. Its menu features Fresh Mex and Fresh Tex favorites including signature items such as slow-smoked baby back ribs, craft burgers, fajitas, and bottomless chips and salsa paired with tableside guacamole. Maggiano's is an Italian restaurant brand with a full lunch and dinner menu offering chef-prepared, such as appetizers, chicken, seafood, veal and prime steaks, and desserts. The company generates maximum revenue from Chili's segment.

Share on Social Networks: